LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 513 | 10151 | 10473 | 0.9694 | 0.9856 |
MCF 10A | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 513 | 927 | 10473 | 0.0885 | 0.1425 |
MCF 10A | Sorafenib | 1.11 | uM | LJP6 | 72 | hr | 513 | 10318 | 10473 | 0.9853 | 0.9927 |
MCF 10A | AZD7762 | 0.12 | uM | LJP6 | 72 | hr | 513 | 4519 | 10473 | 0.4314 | 0.6460 |
MCF 10A | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 513 | 2503 | 10473 | 0.2388 | 0.4339 |
MCF 10A | AZD8055 | 1.11 | uM | LJP6 | 72 | hr | 513 | 1080 | 10473 | 0.1032 | 0.1860 |
MCF 10A | AZD8055 | 10 | uM | LJP6 | 72 | hr | 513 | 840 | 10473 | 0.0802 | 0.1194 |
MCF 10A | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 513 | 10330 | 10473 | 0.9863 | 0.9936 |
MCF 10A | AT-7519 | 1.11 | uM | LJP6 | 72 | hr | 513 | 815 | 10473 | 0.0779 | 0.1117 |
MCF 10A | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 513 | 6866 | 10473 | 0.6556 | 0.8138 |
MCF 10A | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 513 | 936 | 10473 | 0.0894 | 0.1480 |
MCF 10A | AZD7762 | 10 | uM | LJP6 | 72 | hr | 513 | 353 | 10473 | 0.0338 | -0.0823 |
MCF 10A | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 513 | 1215 | 10473 | 0.1160 | 0.2178 |
MCF 10A | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 513 | 1100 | 10473 | 0.1050 | 0.1895 |
MCF 10A | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 513 | 9912 | 10473 | 0.9465 | 0.9748 |
MCF 10A | AZD7762 | 0.37 | uM | LJP6 | 72 | hr | 513 | 3341 | 10473 | 0.3189 | 0.5362 |
MCF 10A | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 513 | 11587 | 10473 | 1.1063 | 1.0468 |
MCF 10A | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 513 | 10401 | 10473 | 0.9931 | 0.9965 |
MCF 10A | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 513 | 7852 | 10473 | 0.7495 | 0.8710 |
MCF 10A | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 513 | 995 | 10473 | 0.0950 | 0.1636 |
MCF 10A | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 513 | 665 | 10473 | 0.0636 | 0.0613 |
MCF 10A | AT-7519 | 10 | uM | LJP6 | 72 | hr | 513 | 482 | 10473 | 0.0461 | -0.0150 |
MCF 10A | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 513 | 1722 | 10473 | 0.1645 | 0.3189 |
MCF 10A | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 513 | 1211 | 10473 | 0.1157 | 0.2180 |
MCF 10A | Sorafenib | 10 | uM | LJP6 | 72 | hr | 513 | 5955 | 10473 | 0.5687 | 0.7566 |